Transexual

The Endocrine Society’s

CLINICAL

GUIDELINES

Endocrine Treatment of Transsexual Persons:
An Endocrine Society Clinical Practice Guideline

Authors: Wylie C. Hembree, Peggy Cohen-Kettenis, Henriette A. Delemarre-van de Waal, Louis J. Gooren, Walter J. Meyer III, Norman P. Spack, Vin Tangpricha, and Victor M. Montori Co-Sponsoring Associations: European Society of Endocrinology, European Society for Paediatric Endocrinology, Lawson Wilkins Pediatric Endocrine Society, and World Professional Association for Transgender Health Affiliations: Columbia University and New York Presbyterian Hospital (W.C.H.), New York, New York; VU Medical Center (P.C-K., H.A.D.-v.d.W.), Amsterdam, The Netherlands; Leiden University Medical Center (H.A.D-v.d.W.), Leiden, The Netherlands; Andro-consult (L.J.G.) ChaingMai, Thailand; University of Texas Medical Branch (W.J.M.), Galveston, Texas; Harvard Medical School (N.P.S.), Boston, Massachusetts; Emory University School of Medicine (V.T.), Atlanta, Georgia; and Mayo Clinic (V.M.M.), Rochester, Minnesota. Disclaimer Statement: Clinical Practice Guidelines are developed to be of assistance to endocrinologists by providing guidance and recommendations for particular areas of practice. The Guidelines should not be considered inclusive of all proper approaches or methods, or exclusive of others. The Guidelines cannot guarantee any specific outcome, nor do they establish a standard of care. The Guidelines are not intended to dictate the treatment of a particular patient. Treatment decisions must be made based on the independent judgment of health care providers and each patient’s individual circumstances. The Endocrine Society makes no warranty, express or implied, regarding the Guidelines and specifically excludes any warranties of merchantability and fitness for a particular use or purpose. The Society shall not be liable for direct, indirect, special, incidental, or consequential damages related to the use of the information...